PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18074035-1	2007	BACKGROUND: Nitrosylcobalamin (NO-Cbl) is a chemotherapeutic pro-drug derived from vitamin B12 that preferentially delivers nitric oxide (NO) to tumor cells, based upon increased receptor expression.	Nitric Oxide	124-136	Cbl proto-oncogene	Homo sapiens	34-37	
26246372-1	2015	The interaction with nitric oxide (NO) is an important aspect of the biological activity of vitamin B12 (Cbl).	Nitric Oxide	21-33	Cbl proto-oncogene	Homo sapiens	105-108	
11978125-1	2002	Electrochemistry and Raman spectroscopy have shown that aquocob(III)alamin (Cbl(III)) can be reduced by nitric oxide (NO) to form Cbl(II) on an electrode surface.	Nitric Oxide	104-116	Cbl proto-oncogene	Homo sapiens	64-67	
16847314-1	2006	We have previously demonstrated that nitrosylcobalamin (NO-Cbl), an analogue of vitamin B12 that delivers nitric oxide (NO), had potent antiproliferative activity against several human cancer cell lines.	Nitric Oxide	106-118	Cbl proto-oncogene	Homo sapiens	59-62	
12881518-1	2003	We have previously demonstrated the anti-tumor activity of nitrosylcobalamin (NO-Cbl), an analog of vitamin B12 that delivers nitric oxide (NO) and increases the expression of tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) and its receptors in human tumors.	Nitric Oxide	126-138	Cbl proto-oncogene	Homo sapiens	81-84	
11978125-1	2002	Electrochemistry and Raman spectroscopy have shown that aquocob(III)alamin (Cbl(III)) can be reduced by nitric oxide (NO) to form Cbl(II) on an electrode surface.	Nitric Oxide	104-116	Cbl proto-oncogene	Homo sapiens	76-84	
11978125-1	2002	Electrochemistry and Raman spectroscopy have shown that aquocob(III)alamin (Cbl(III)) can be reduced by nitric oxide (NO) to form Cbl(II) on an electrode surface.	Nitric Oxide	104-116	Cbl proto-oncogene	Homo sapiens	76-79	
11583539-1	2001	The reduced form of aquacobalamin binds nitric oxide very effectively to yield a nitrosyl adduct, Cbl(II)-NO.	Nitric Oxide	40-52	Cbl proto-oncogene	Homo sapiens	98-108	
9580611-1	1998	Recent reports indicate that oxidized cobalamin, Cbl(III), can interfere with the biological effects of nitric oxide (NO) on vascular and visceral smooth muscle and in other systems.	Nitric Oxide	104-116	Cbl proto-oncogene	Homo sapiens	49-52	
9580611-8	1998	Nitric oxide also reacts rapidly and irreversibly with the superoxo complex of Cbl(III), Cbl(III)O2-, which is always present in aerated solutions of Cbl(III).	Nitric Oxide	0-12	Cbl proto-oncogene	Homo sapiens	79-82	
9580611-8	1998	Nitric oxide also reacts rapidly and irreversibly with the superoxo complex of Cbl(III), Cbl(III)O2-, which is always present in aerated solutions of Cbl(III).	Nitric Oxide	0-12	Cbl proto-oncogene	Homo sapiens	89-92	
9580611-8	1998	Nitric oxide also reacts rapidly and irreversibly with the superoxo complex of Cbl(III), Cbl(III)O2-, which is always present in aerated solutions of Cbl(III).	Nitric Oxide	0-12	Cbl proto-oncogene	Homo sapiens	89-92	
33288568-3	2020	We have previously demonstrated the anti-tumor activity of a nitric oxide-donor, nitrosylcobalamin (NO-Cbl), mediated by increased expression of tumor necrosis factor-related apoptosis-inducing ligand (Apo2L/TRAIL) and its receptors in human tumors.	Nitric Oxide	61-73	Cbl proto-oncogene	Homo sapiens	103-106